Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000185690 | SCV000238611 | pathogenic | not provided | 2017-12-08 | criteria provided, single submitter | clinical testing | R330C missense mutations in the ACADS gene have been reported previously in association with short chain acyl-CoA dehydrogenase (SCAD) deficiency (van Maldegem et al., 2006). The variant is found in ACADS panel(s). |
Fulgent Genetics, |
RCV000762888 | SCV000893277 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000762888 | SCV000942230 | pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 330 of the ACADS protein (p.Arg330Cys). This variant is present in population databases (rs140853839, gnomAD 0.2%). This missense change has been observed in individual(s) with short-chain acyl-coA dehydrogenase (SCAD) deficiency (PMID: 16926354, 18676165; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 203557). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ACADS protein function. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000762888 | SCV002023979 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000762888 | SCV002033280 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252029 | SCV002522862 | likely pathogenic | See cases | 2021-10-15 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PS4, PM2, PM3, PP3 |
Counsyl | RCV000762888 | SCV001132320 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2016-12-21 | no assertion criteria provided | clinical testing | |
Neonatal Disease Screening Center, |
RCV000762888 | SCV004800871 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | no assertion criteria provided | clinical testing | PM2_P+PM3_S+PM5+PP3+PP4 |